1. OP0085 Safety of long-term (UP TO 6 YEARS) canakinumab therapy (<2, 2−<4 and 4−<8mg/kg) in patients aged <4 to 65 years from beta-confident registry. (12th June 2018) Authors: Kuemmerle-Deschner, J.B.; Walker, U.A.; Tilson, H.H.; Hawkins, P.N.; van der Poll, T.; Franke, K.; Speziale, A.; Vritzali, E.; Hoffman, H.H. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗